FHL3
FHL3geneFHL3 is a CAD-variant-regulated smooth muscle gene that modulates vascular inflammation and structural adaptation in atherosclerosis.
Pathway placement
Cascade stepPlaque inflammation
Confidencelow
RationaleCAD-variant SMC regulator; involved in vascular stress response.
Also acts inEndothelial activation/erosion
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000183386
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Coronary artery disease-associated variants regulate vascular smooth muscle cell gene expression.Nature cardiovascular research · 2025 · PMID 41057608 · doi